Peptides such as GLP-1 agonists require continuous administration to maintain their benefits
Cagrilintide Structure CAS #: N/A Quantity: 5 mg Molecular Formula: CHNOS Molecular Weight: 6781.6 g/mol PubChem ID: 137465331 AQ1-S Structure CAS #: 910463-68-2 Quantity: 6 mg Vials: 10 vials per kit Molecular Formula: CHNO Molecular Weight: 4113.6 g/mol PubChem ID: 56843331 Research Use Only For laboratory research use only
The authors reported that BPC 157 alone (without carrier) ameliorates healing of tendon and bone in the experimental rat model, with macroscopic, microscopic, and biomechanical assessments showing recovery of the tendon-to-bone unit that was not observed in untreated controls [3]
Proceedings of the National Academy of Sciences of the United States of America, 86(16), 62306234
Unanticipated Cellular Effects: As a mitochondrial peptide, it could affect cellular energy processes in harmful ways
Tirzepatide with B12 is popular because GLP-1 medications can sometimes reduce absorption of certain vitamins, and B12 deficiency is associated with fatigue, a side effect some tirzepatide users report